Vir Biotechnology, Inc. is a clinical-stage immunology company headquartered in San Francisco, California, focused on leveraging its proprietary technologies to develop therapeutic solutions for serious infectious diseases. With a robust pipeline targeting viral pathogens, including its innovative monoclonal antibodies and immunotherapeutics, Vir aims to address unmet medical needs in areas such as COVID-19 and influenza. The company's strategic partnerships and collaborations enhance its research capabilities, positioning it as a key player in the biotechnology sector dedicated to improving global health outcomes.
Click "Analyze" to generate stock analysis
VIR Price Trend and Signals
VIR Option Volumes & Open Interests (aggregated)
VIR Put Call Ratios and IV (aggregated)
VIR Financials
2025-10-29Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-28Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-28Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-28Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-28Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-28Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-28Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.